General
EU gives green light to AstraZeneca COVID-19 vaccine despite German concerns
Europe’s medicines regulator has approved AstraZeneca and Oxford University’s COVID-19 vaccine for people over the age of 18, making it the third vaccine to be cleared for use in the European Union.
Key points:
- The European Medicines Agency said the jab had an efficacy of around 60 per cent in trials
- It said it expected the vaccine would offer protection to elderly people
- Germany had recommended the vaccine only be given to people aged between 18 and 64
The AstraZeneca vaccine demonstrated an efficacy of around 60 per cent in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement.
The 60 per cent efficacy rate raised some concerns the AstraZeneca vaccine offers less protection than ones already…
-
Noosa News14 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General15 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
Noosa News21 hours agoMollie O’Callaghan admits to doubts, wins gold at Australian Open Swimming Championships
-
Noosa News14 hours agoQueensland woman charged with murdering partner with MND allegedly fed him ‘cocktail’ of medications